European regulators gave Boston Scientific (NYSE:BSX) the green light for its Guide 3D imaging system, touting it as the "world’s first" deep-brain stimulation visualization system.
The Guide device is designed to create a simulated 3D map of the brain’s electrical output, to help guide the placement of electrodes that deliver electrical pulses to the brain.